NASDAQ:OPHT - Ophthotech News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.39 -0.04 (-2.80 %)
(As of 01/17/2019 08:11 AM ET)
Previous Close$1.43
Today's Range$1.3680 - $1.43
52-Week Range$1.02 - $4.50
Volume79,240 shs
Average Volume358,469 shs
Market Capitalization$59.01 million
P/E Ratio0.44
Dividend YieldN/A
Beta1.49

Headlines

Ophthotech (NASDAQ OPHT) News Headlines

Source:
DateHeadline
Ophthotech (OPHT) Presents At 37th Annual J.P. Morgan Healthcare Conference - SlideshowOphthotech (OPHT) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 11 at 6:45 PM
Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare ConferenceOphthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 8:16 AM
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of DirectorsOphthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors
finance.yahoo.com - January 2 at 8:16 AM
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of DirectorsOphthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors
finance.yahoo.com - December 12 at 4:22 PM
Ophthotech (OPHT) Down 21.7% Since Last Earnings Report: Can It Rebound?Ophthotech (OPHT) Down 21.7% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - November 30 at 5:58 PM
Ophthotech Corp (OPHT) Reports Results from Phase 2a Safety Trial of Zimura (avacincaptad pegol) in Combination ...Ophthotech Corp (OPHT) Reports Results from Phase 2a Safety Trial of Zimura (avacincaptad pegol) in Combination ...
www.streetinsider.com - November 14 at 5:24 PM
BRIEF-Ophthotech Announces Results From Phase 2A Safety Trial Of Zimura In Combination With Lucentis In Wet Age-Related Macular DegenerationBRIEF-Ophthotech Announces Results From Phase 2A Safety Trial Of Zimura In Combination With Lucentis In Wet Age-Related Macular Degeneration
www.msn.com - November 12 at 8:17 AM
Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular DegenerationOphthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration
finance.yahoo.com - November 12 at 8:17 AM
Form 10-Q Ophthotech Corp. For: Sep 30Form 10-Q Ophthotech Corp. For: Sep 30
www.streetinsider.com - November 4 at 8:16 AM
Form 8-K Ophthotech Corp. For: Oct 30Form 8-K Ophthotech Corp. For: Oct 30
www.streetinsider.com - November 2 at 8:09 AM
Ophthotech (OPHT) Q3 Earnings Beat, Gene Therapy in FocusOphthotech (OPHT) Q3 Earnings Beat, Gene Therapy in Focus
finance.yahoo.com - November 1 at 6:11 PM
Edited Transcript of OPHT earnings conference call or presentation 31-Oct-18 12:00pm GMTEdited Transcript of OPHT earnings conference call or presentation 31-Oct-18 12:00pm GMT
finance.yahoo.com - November 1 at 8:07 AM
Ophthotech Corporation 2018 Q3 - Results - Earnings Call SlidesOphthotech Corporation 2018 Q3 - Results - Earnings Call Slides
seekingalpha.com - October 31 at 5:35 PM
Ophthotech Corporation (OPHT) CEO Glenn Sblendorio on Q3 2018 Results - Earnings Call TranscriptOphthotech Corporation (OPHT) CEO Glenn Sblendorio on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - October 31 at 5:35 PM
Ophthotech acquires Inception 4 in all-stock dealOphthotech acquires Inception 4 in all-stock deal
seekingalpha.com - October 31 at 8:13 AM
Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4
finance.yahoo.com - October 31 at 8:13 AM
Ophthotech Reports Third Quarter 2018 Financial and Operating ResultsOphthotech Reports Third Quarter 2018 Financial and Operating Results
finance.yahoo.com - October 31 at 8:13 AM
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease)Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease)
finance.yahoo.com - October 31 at 8:13 AM
Ophthotech: 3Q Earnings SnapshotOphthotech: 3Q Earnings Snapshot
finance.yahoo.com - October 31 at 8:13 AM
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday ...Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday ...
www.businesswire.com - October 23 at 8:11 AM
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018
finance.yahoo.com - October 23 at 8:11 AM
Form 8-K Ophthotech Corp. For: Oct 04Form 8-K Ophthotech Corp. For: Oct 04
www.streetinsider.com - October 5 at 8:16 AM
Ophthotech completes patient recruitment for its Phase 2b clinical trial of ZimuraOphthotech completes patient recruitment for its Phase 2b clinical trial of Zimura
seekingalpha.com - October 4 at 4:56 PM
Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular DegenerationOphthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
finance.yahoo.com - October 4 at 8:11 AM
Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines ConferenceOphthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference
finance.yahoo.com - October 3 at 8:17 AM
Is Ophthotech Corporation (NASDAQ:OPHT) Attractive At Its Current PE Ratio?Is Ophthotech Corporation (NASDAQ:OPHT) Attractive At Its Current PE Ratio?
finance.yahoo.com - September 12 at 4:54 PM
Why Is Ophthotech (OPHT) Up 5.8% Since Last Earnings Report?Why Is Ophthotech (OPHT) Up 5.8% Since Last Earnings Report?
finance.yahoo.com - August 31 at 5:19 PM
Ophthotech Corp (OPHT) Says Data for Adeno-Associated Virus Gene Therapy in RHO-adRP Published in PNASOphthotech Corp (OPHT) Says Data for Adeno-Associated Virus Gene Therapy in RHO-adRP Published in PNAS
www.streetinsider.com - August 22 at 5:04 PM
Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of SciencesScientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences
finance.yahoo.com - August 22 at 8:17 AM
Report: Developing Opportunities within Energy Recovery, Lamb Weston, Neurocrine Biosciences, Pioneer Natural Resources, Meritor, and Ophthotech — Future Expectations, Projections Moving into 2018Report: Developing Opportunities within Energy Recovery, Lamb Weston, Neurocrine Biosciences, Pioneer Natural Resources, Meritor, and Ophthotech — Future Expectations, Projections Moving into 2018
finance.yahoo.com - August 13 at 8:09 AM
Form 10-Q Ophthotech Corp. For: Jun 30Form 10-Q Ophthotech Corp. For: Jun 30
www.streetinsider.com - August 3 at 4:40 PM
Edited Transcript of OPHT earnings conference call or presentation 1-Aug-18 12:00pm GMTEdited Transcript of OPHT earnings conference call or presentation 1-Aug-18 12:00pm GMT
finance.yahoo.com - August 2 at 8:12 AM
Ophthotech Corp (OPHT) Tops Q2 EPS by 2cOphthotech Corp (OPHT) Tops Q2 EPS by 2c
www.streetinsider.com - August 1 at 5:59 PM
Ophthotech Corp (OPHT) CEO Glenn Sblendorio on Q2 2018 Results - Earnings Call TranscriptOphthotech Corp (OPHT) CEO Glenn Sblendorio on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 1 at 5:59 PM
Ophthotech files for $150M mixed shelf offering; share down 2% after hoursOphthotech files for $150M mixed shelf offering; share down 2% after hours
seekingalpha.com - August 1 at 5:59 PM
Robbins Arroyo LLP: Ophthotech Corporation (OPHT) Misled Shareholders According to a Consolidated Amended Class Action ComplaintRobbins Arroyo LLP: Ophthotech Corporation (OPHT) Misled Shareholders According to a Consolidated Amended Class Action Complaint
www.bizjournals.com - August 1 at 8:13 AM
Ophthotech Reports Second Quarter 2018 Financial and Operating ResultsOphthotech Reports Second Quarter 2018 Financial and Operating Results
finance.yahoo.com - August 1 at 8:13 AM
Ophthotech: 2Q Earnings SnapshotOphthotech: 2Q Earnings Snapshot
finance.yahoo.com - August 1 at 8:13 AM
Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018
finance.yahoo.com - July 25 at 5:40 PM
Free Technical Research on OPKO Health and Three More Biotech EquitiesFree Technical Research on OPKO Health and Three More Biotech Equities
finance.yahoo.com - July 17 at 8:10 AM
electroCore, Inc. Announces Additions to Board of Directors in Connection with Recently Completed Initial Public OfferingelectroCore, Inc. Announces Additions to Board of Directors in Connection with Recently Completed Initial Public Offering
finance.yahoo.com - July 10 at 8:12 AM
Ophthotech (OPHT) Soars: Stock Adds 10.4% in SessionOphthotech (OPHT) Soars: Stock Adds 10.4% in Session
www.zacks.com - June 8 at 8:12 AM
Ophthotech Corp (OPHT) Announces Gene Therapy Agreements with University of Florida and PennOphthotech Corp (OPHT) Announces Gene Therapy Agreements with University of Florida and Penn
www.streetinsider.com - June 7 at 5:31 PM
Ophthotech inks gene therapy agreements for RP candidate; shares ahead 13% premarketOphthotech inks gene therapy agreements for RP candidate; shares ahead 13% premarket
seekingalpha.com - June 7 at 5:31 PM
Ophthotech Gains on Gene Pacts with UniversitiesOphthotech Gains on Gene Pacts with Universities
www.baystreet.ca - June 7 at 5:31 PM
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of PennsylvaniaOphthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania
finance.yahoo.com - June 7 at 8:12 AM
Recent Analysis Shows PHH, Stanley Black & Decker, Invacare, Ophthotech, Party City Holdco, and Hyatt Hotels ...Recent Analysis Shows PHH, Stanley Black & Decker, Invacare, Ophthotech, Party City Holdco, and Hyatt Hotels ...
www.nasdaq.com - May 14 at 5:25 PM
Form DEFA14A Ophthotech Corp.Form DEFA14A Ophthotech Corp.
www.streetinsider.com - May 14 at 5:25 PM
Recent Analysis Shows PHH, Stanley Black & Decker, Invacare, Ophthotech, Party City Holdco, and Hyatt Hotels Market Influences — Renewed Outlook, Key Drivers of GrowthRecent Analysis Shows PHH, Stanley Black & Decker, Invacare, Ophthotech, Party City Holdco, and Hyatt Hotels Market Influences — Renewed Outlook, Key Drivers of Growth
finance.yahoo.com - May 14 at 8:18 AM
Ophthotechs (OPHT) Q1 Loss Narrows Y/Y, Zimura in FocusOphthotech's (OPHT) Q1 Loss Narrows Y/Y, Zimura in Focus
www.nasdaq.com - May 10 at 6:05 PM
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Featured Article: What is the quiet period?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel